首页> 美国卫生研究院文献>Journal of Cancer >MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients
【2h】

MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients

机译:侵袭性肺腺癌固体亚型的MicroRNA表达谱揭示了一组与中国患者预后不良相关的四个miRNA

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

According to the reclassification of lung adenocarcinoma (LAC) proposed in 2011, solid predominant lung adenocarcinoma (SPA) has been associated with poor outcomes for LAC patients. However, the prognostic value of the presence of solid subtype remains unclear. Besides, there is little data about the roles of microRNA (miRNA) in solid subtype of LAC. In this study, 243 LAC patients were classified into solid subtype positive and negative groups (S+ LAC, n=134 and S- LAC, n=109) according to whether the solid subtype was more than 5% of the tumor component or not. We analyzed the relationship between solid subtype and patients' outcome by univariate and multivariate analyses. Solid subtype was proved to be significantly associated with the 5-year overall survival and played as an independent prognostic factor for stage I-III invasive LAC patients. Then miRNA microarray was used to identify differentially expressed miRNAs in solid subtype, resulting in 31 differential miRNAs. Quantitative reverse transcription-PCR (QRT-PCR) was used to validate 4 key miRNAs (miR-133b, miR-155-5p, miR-124-3p, miR-145-5p). Further, CCK-8 and transwell assays were performed to validate the impact of one dysregulated miRNA (miR-133b) on LAC cell function. Interestingly, while miR-133b could significantly inhibit the proliferation of A549 and SPC-A1, it showed no effect on the migration or invasion of LAC cell lines. These results suggest that solid subtype can exert independent prognostic impact on LAC patients, and 4 important dysregulated miRNAs in solid subtype of LAC may be involved in the malignancy of S+LAC, thus may further have clinical perspective for S+ LAC in the future.
机译:根据2011年提出的肺腺癌(LAC)的重新分类,以固体为主的肺腺癌(SPA)与LAC患者预后不良相关。然而,存在固体亚型的预后价值仍不清楚。此外,关于微RNA(miRNA)在LAC的固体亚型中的作用的数据很少。在这项研究中,根据实体亚型是否超过肿瘤成分的5%,将243名LAC患者分为实体亚型阳性和阴性组(S + LAC,n = 134和S-LAC,n = 109)。我们通过单因素和多因素分析来分析实体亚型与患者预后之间的关系。实心亚型被证明与5年总生存率显着相关,并作为I-III期浸润性LAC患者的独立预后因素。然后使用miRNA微阵列鉴定固体亚型中差异表达的miRNA,从而产生31个差异miRNA。定量逆转录PCR(QRT-PCR)用于验证4种关键miRNA(miR-133b,miR-155-5p,miR-124-3p,miR-145-5p)。此外,进行了CCK-8和transwell分析以验证一种失调的miRNA(miR-133b)对LAC细胞功能的影响。有趣的是,尽管miR-133b可以显着抑制A549和SPC-A1的增殖,但它对LAC细胞系的迁移或侵袭没有影响。这些结果表明,固体亚型可以对LAC患者产生独立的预后影响,并且固体亚型中的4种重要的失调的miRNA可能与S + LAC的恶性肿瘤有关,因此将来可能对S + LAC具有临床前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号